Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Vucinic, V.
52  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Clinical implications and dynamics of clonal hematopoiesis ..:

Panagiota, V ; Kerschbaum, J.F ; Penack, O...
http://edoc.mdc-berlin.de/23781/1/23781oa.pdf.  , 2023
Link: http://edoc.mdc-berlin.d..
 
?
2

P1087: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKA..:

Herrera, A. F ; Lavie, D ; Johnson, N. A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430340/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

P1086: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKA..:

Gregory, G ; Timmerman, J ; Lavie, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428990/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Brentuximab vedotin-containing escalated BEACOPP variants f..:

Damaschin, C ; Goergen, H ; Kreissl, S...
http://edoc.mdc-berlin.de/20855/1/20855oa.pdf.  , 2022
Link: http://edoc.mdc-berlin.d..
 
?
5

P1313: PREDICTING OUTCOMES IN AML PATIENTS CONSOLIDATED BY ..:

Jentzsch, M ; Herrmann, L ; Bischof, L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430766/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

P1381: EARLY FULL DONOR CHIMERISM AFTER FLAMSA RIC BASED AL..:

Ussmann, J ; Hell, S ; Schetschorke, B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430457/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

P1356: PATIENT-SPECIFIC DIGITAL DROPLET PCR ASSAYS FOR MINI..:

Jentzsch, M ; Bischof, L ; Backhaus, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429420/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

P1448: LONG-TERM SURVIVORS AFTER FAILURE OF CAR-T CELL THER..:

Derigs, P ; Bethge, W ; Holtick, U...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429516/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

The feasibility and efficacy of subcutaneous plerixafor for..:

Greef, Georgine ; Braakman, Eric ; van der Holt, Ronnie...
Greef , G , Braakman , E , van der Holt , R , Janssen , JJWM , Petersen , E , Vucinic , V , Thuss , N , Grootes , MEB & Cornelissen , J 2019 , ' The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study ' , Transfusion , vol. 59 , no. 1 , pp. 316-324 . https://doi.org/10.1111/trf.15037.  , 2019
Link: https://pure.eur.nl/en/p..
 
?
10

Fludarabine/2 Gy TBI is Superior to 2 Gy TBI as Conditionin..:

Kornblit B ; Maloney DG ; Storb R...
info:eu-repo/semantics/altIdentifier/pmid/23769990.  , 2013
Link: http://hdl.handle.net/23..
 
?
11

A Randomized Phase III Trial Investigating 2 Gy TBI Vs. Flu..:

Kornblit, B ; Storer, B ; Storb, R.F...
https://www.openaccessrepository.it/record/24713.  , 2012
Link: https://www.openaccessre..
 
?
12

The feasibility and efficacy of subcutaneous plerixafor for..:

Greef, G.E. (Georgine) de ; Braakman, E. (Eric) ; Holt, B. (Bronno) van der...
http://repub.eur.nl/pub/113231.  , 2018
Link: http://repub.eur.nl/pub/..
 
?
13

P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURAB..:

L. Bischof ; J. Ussmann ; D. Brauer...
http://journals.lww.com/10.1097/01.HS9.0000844924.32286.18.  , 2022
Link: https://doi.org/10.1097/..
 
?
14

P1087: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKA..:

A. F. Herrera ; D. Lavie ; N. A. Johnson...
http://journals.lww.com/10.1097/01.HS9.0000847216.85071.f3.  , 2022
Link: https://doi.org/10.1097/..
 
?
15

P1381: EARLY FULL DONOR CHIMERISM AFTER FLAMSA RIC BASED AL..:

J. Ussmann ; S. Hell ; B. Schetschorke...
http://journals.lww.com/10.1097/01.HS9.0000848384.19117.7c.  , 2022
Link: https://doi.org/10.1097/..
 
1-15